Champlain Investment Partners’s St Jude Medical STJ Stock Holding History
Bought
Maintained
Sold
Other funds holding STJ
FCM
BIT
BFA
Champlain Investment Partners's STJ Position: Q4 2016 in Review
Champlain Investment Partners sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 697,285 shares — an estimated $55.6M sold.
Champlain Investment Partners first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $86.9M in Q2 2015. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.
- Champlain Investment Partners reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
- Champlain Investment Partners sold 697,285 St Jude Medical shares in Q4 2016, an estimated $55.6M.
- Champlain Investment Partners first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
- Champlain Investment Partners's St Jude Medical position peaked at $86.9M in Q2 2015.
- 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.
Based on Champlain Investment Partners's 13F filing for Q4 2016, filed 13 Feb 2017.